Whilst a mild, asymptomatic rise in resting heart rate is generally considered an expected pharmacological effect of GLP-1-based therapies, certain presentations should prompt timely medical review
For some, going long periods without eating may be unrealistic, especially if you have a physically demanding job or are very active
Bydureon Bcise (exenatide) used to help control blood sugar levels in patients with type 2 diabetes Tanzeum (albiglutide) used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus Byetta (exenatide) also used in combination with diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus Mounjaro (tirzepatide) a once-weekly glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, the only FDA-approved dual-action GIP and GLP-1 receptor agonist for the treatment of diabetes Which GLP-1 works best for weight loss
doi:10.3389/fimmu.2023.1148209 102
Coretti L, Cuomo M, Florio E, et al
Cagrilintide monotherapy data is more limited